Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jul;60(7):e71189.
doi: 10.1002/ppul.71189.

Randomized Cross-Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia

Affiliations
Randomized Controlled Trial

Randomized Cross-Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia

Anna Charlotte Schoop et al. Pediatr Pulmonol. 2025 Jul.

Abstract

Background: When monitoring lung function in patients with Cystic Fibrosis (pwCF) and Primary Ciliary Dyskinesia (pwPCD), nitrogen multiple breath washout (N2MBW) is usually performed before spirometry to prevent forced expiratory maneuvers from altering N2MBW results. The N2MBW may affect spirometry if cooperation decreases after a long period of examination or due to prolonged oxygen inhalation. The equivalence of these concepts has never been investigated in a randomized cross-over trial. We hypothesized that the order of pulmonary function tests (PFTs) would not influence the z-score FEV1.

Methods: A total of 47 clinically stable outpatients (36 pwCF, 11 pwPCD; 16.7 ± 8.1 years) were randomized into two groups. Each patient underwent N2MBW and spirometry at two consecutive visits (median interval 104 days): Group I: Spirometry followed by N2MBW (A), reversed order at the second visit (B), Group II reversed (B→A).

Statistics: For the equivalence test, a change in z-score FEV1 (primary endpoint) ±0.2 and lung clearance index (LCI2.5, secondary endpoint) ±15% was not considered relevant; therefore, changes outside this range were considered an intervention effect in the linear mixed model (p < 0.05).

Results: There was a significant deterioration in z-score FEV1 between the two appointments (period effect: -0.177; p = 0.012). The intervention effect and 95% confidence interval were within the equivalence range in both groups (z-score FEV1: 0.039; -0.0765 to 0.1539, LCI2.5: -0.082; -0.3691 to 0.2054).

Discussion: In our cohort the order of PFTs has no influence on the results suggesting that a greater flexibility in practice is possible without the risk of falsifying results.

Trial registration: German Clinical Trials Register (No. DRKS00027473).

Keywords: cystic fibrosis; multiple breath washout; primary ciliary dyskinesia; spirometry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart of the recruitment process of the study. PCD = primary ciliary dyskinesia; CF = cystic fibrosis, N2MBW = nitrogen multiple breath washout, FEV1 = forced expiratory volume after 1 s, A: spirometry first, nitrogen multiple breath washout second, B: nitrogen multiple breath washout first, spirometry second.
Figure 2
Figure 2
(A) Bland–Altman plot for z‐score FEV1 (N = 47); x‐axis: average of both appointments, y‐axis: difference between both measurements (Appointment A − Appointment B), gray dashed lines: upper and lower 95% confidence interval, black dots: mean values of the individuals in relation to the difference of the values. (B) Bland–Altman plot for LCI2.5 (N = 44); x‐axis: average of both appointments, y‐axis: difference between both measurements (Appointment A − Appointment B), gray dashed lines: upper and lower 95% confidence interval, black dots: mean values of the individuals in relation to the difference of the values, FEV1 = forced expiratory volume after 1 s, z‐score: calculation according to Global Lung Initiative reference values (see methods), LCI2.5 = lung clearance index. Appointment A: spirometry first, nitrogen multiple breath washout second. Appointment B: nitrogen multiple breath washout first, spirometry second.
Figure 3
Figure 3
(A) Visualization of confidence interval of intervention effect on z‐score FEV1 with equivalence range; x‐axis: changes in z‐score FEV1; black line: 95% confidence interval of the Intervention effect N2MBW‐spirometry on z‐score FEV1; black dashed lines mark the equivalence range, black dot: intervention effect. (B) Visualization of confidence interval of intervention effect on LCI2.5; x‐axis: changes in LCI2.5; black line: 95% confidence interval of the intervention effect spirometry–N2MBW on LCI2.5, black dashed lines mark the maximum accepted change between appointments, black dot: intervention effect. FEV1 = forced expiratory volume after 1 s, z‐score: calculation according to Global Lung Initiative reference values (see Methods), N2MBW = nitrogen multiple breath washout; LCI2.5 = lung clearance index.

Similar articles

References

    1. Engelhardt J. F., Yankaskas J. R., Ernst S. A., et al., “Submucosal Glands Are the Predominant Site of CFTR Expression in the Human Bronchus,” Nature Genetics 2, no. 3 (1992): 240–248, 10.1038/ng1192-240. - DOI - PubMed
    1. Kerem B.‐S., Rommens J. M., Buchanan J. A., et al., “Identification of the Cystic Fibrosis Gene: Genetic Analysis,” Science 245, no. 4922 (1989): 1073–1080, 10.1126/science.2570460. - DOI - PubMed
    1. Riordan J. R., Rommens J. M., Kerem B. S., et al., “Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA,” Science 245, no. 4922 (1989): 1066–1073, 10.1126/science.2475911. - DOI - PubMed
    1. Pifferi M., Bush A., Mariani F., et al., “Lung Function Longitudinal Study by Phenotype and Genotype in Primary Ciliary Dyskinesia,” Chest 158, no. 1 (2020): 117–120, 10.1016/j.chest.2020.02.001. - DOI - PubMed
    1. Kinghorn B., Rosenfeld M., Sullivan E., et al., “Airway Disease in Children With Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and Genotype,” Annals of the American Thoracic Society 20, no. 4 (2023): 539–547, 10.1513/AnnalsATS.202206-524OC. - DOI - PMC - PubMed

Publication types